144 related articles for article (PubMed ID: 24786858)
1. Beta-blocker usage and prostate cancer survival: a nested case-control study in the UK Clinical Practice Research Datalink cohort.
Cardwell CR; Coleman HG; Murray LJ; O'Sullivan JM; Powe DG
Cancer Epidemiol; 2014 Jun; 38(3):279-85. PubMed ID: 24786858
[TBL] [Abstract][Full Text] [Related]
2. β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort.
Hicks BM; Murray LJ; Powe DG; Hughes CM; Cardwell CR
Ann Oncol; 2013 Dec; 24(12):3100-6. PubMed ID: 24050955
[TBL] [Abstract][Full Text] [Related]
3. Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort.
Cardwell CR; Coleman HG; Murray LJ; Entschladen F; Powe DG
Int J Epidemiol; 2013 Dec; 42(6):1852-61. PubMed ID: 24536096
[TBL] [Abstract][Full Text] [Related]
4. Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study.
McCourt C; Coleman HG; Murray LJ; Cantwell MM; Dolan O; Powe DG; Cardwell CR
Br J Dermatol; 2014 Apr; 170(4):930-8. PubMed ID: 24593055
[TBL] [Abstract][Full Text] [Related]
5. Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts.
Cardwell CR; Mc Menamin ÚC; Hicks BM; Hughes C; Cantwell MM; Murray LJ
BMC Med; 2014 Feb; 12():28. PubMed ID: 24521426
[TBL] [Abstract][Full Text] [Related]
6. Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink.
Cardwell CR; Flahavan EM; Hughes CM; Coleman HG; O'Sullivan JM; Powe DG; Murray LJ
Cancer Causes Control; 2014 Jan; 25(1):33-43. PubMed ID: 24310109
[TBL] [Abstract][Full Text] [Related]
7. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA
Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
[TBL] [Abstract][Full Text] [Related]
8. Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer.
Assayag J; Pollak MN; Azoulay L
Eur J Cancer; 2014 Nov; 50(16):2838-45. PubMed ID: 25204805
[TBL] [Abstract][Full Text] [Related]
9. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
[TBL] [Abstract][Full Text] [Related]
10. Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA; Håheim LL
Prostate; 2013 Feb; 73(3):250-60. PubMed ID: 22821802
[TBL] [Abstract][Full Text] [Related]
11. Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice Research Datalink.
Murray LJ; Cooper JA; Hughes CM; Powe DG; Cardwell CR
Breast Cancer Res; 2014 Apr; 16(2):R34. PubMed ID: 24708725
[TBL] [Abstract][Full Text] [Related]
12. Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients.
Hicks BM; Murray LJ; Hughes C; Cardwell CR
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):830-40. PubMed ID: 26017274
[TBL] [Abstract][Full Text] [Related]
13. Can analyses of electronic patient records be independently and externally validated? Study 2--the effect of β-adrenoceptor blocker therapy on cancer survival: a retrospective cohort study.
Springate DA; Ashcroft DM; Kontopantelis E; Doran T; Ryan R; Reeves D
BMJ Open; 2015 Apr; 5(4):e007299. PubMed ID: 25869690
[TBL] [Abstract][Full Text] [Related]
14. Resource Utilization Among Glaucoma Patients in the UK Treated with Beta-Blocker and Non-Beta-Blocker Adjunctive Therapy: A Retrospective Cohort Analysis.
Viswanathan A; Spera C; Mullins A; Covert D; Banhazi J; McDwyer P; Hudson E; Ferreira A
Adv Ther; 2017 Jul; 34(7):1695-1706. PubMed ID: 28608143
[TBL] [Abstract][Full Text] [Related]
15. Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study.
Weberpals J; Jansen L; Haefeli WE; Hoffmeister M; Wolkewitz M; Herk-Sukel MPPV; Vissers PAJ; Brenner H
Sci Rep; 2017 Jun; 7(1):2911. PubMed ID: 28588274
[TBL] [Abstract][Full Text] [Related]
16. Preoperative chronic beta-blocker prescription in elderly patients as a risk factor for postoperative mortality stratified by preoperative blood pressure: a cohort study.
Venkatesan S; Jørgensen ME; Manning HJ; Andersson C; Mozid AM; Coburn M; Moonesinghe SR; Foex P; Mythen M; Grocott MPW; Hardman JG; Myles PR; Sanders RD
Br J Anaesth; 2019 Aug; 123(2):118-125. PubMed ID: 31101323
[TBL] [Abstract][Full Text] [Related]
17. 5-Alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial.
Murtola TJ; Karppa EK; Taari K; Talala K; Tammela TL; Auvinen A
Int J Cancer; 2016 Jun; 138(12):2820-8. PubMed ID: 26804670
[TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes and the risk of mortality among patients with prostate cancer.
Bensimon L; Yin H; Suissa S; Pollak MN; Azoulay L
Cancer Causes Control; 2014 Mar; 25(3):329-38. PubMed ID: 24384808
[TBL] [Abstract][Full Text] [Related]
19. Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.
Weberpals J; Jansen L; van Herk-Sukel MPP; Kuiper JG; Aarts MJ; Vissers PAJ; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):1019-1031. PubMed ID: 28864947
[TBL] [Abstract][Full Text] [Related]
20. Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case-control analysis of a population-based cohort.
Cardwell CR; Kunzmann AT; Cantwell MM; Hughes C; Baron JA; Powe DG; Murray LJ
Gastroenterology; 2014 Mar; 146(3):700-708.e2. PubMed ID: 24239563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]